Ho, Wing-Hong Jonathan
Marinova, Maria B
Listijono, Dave R
Bertoldo, Michael J
Richani, Dulama
Kim, Lynn-Jee
Brown, Amelia
Riepsamen, Angelique H
Cabot, Safaa
Frost, Emily R https://orcid.org/0000-0001-8696-2136
Bustamante, Sonia https://orcid.org/0000-0002-5411-2919
Zhong, Ling
Selesniemi, Kaisa
Wong, Derek
Madawala, Romanthi
Marchante, Maria https://orcid.org/0009-0006-7560-6076
Goss, Dale M
Li, Catherine
Araki, Toshiyuki https://orcid.org/0000-0003-3625-2042
Livingston, David J
Turner, Nigel
Sinclair, David A https://orcid.org/0000-0002-9936-436X
Walters, Kirsty A
Homer, Hayden A https://orcid.org/0000-0002-3104-0449
Gilchrist, Robert B https://orcid.org/0000-0003-1611-7142
Wu, Lindsay E https://orcid.org/0000-0002-1599-7574
Funding for this research was provided by:
DHAC | National Health and Medical Research Council (APP1139763)
DHAC | National Health and Medical Research Council (APP1127821)
DHAC | National Health and Medical Research Council (APP2009940)
DHAC | National Health and Medical Research Council (APP1103689)
DHAC | National Health and Medical Research Council (APP1122484)
DHAC | National Health and Medical Research Council (APP1117538)
American Federation for Aging Research (Hevolution New Investigator Award in Aging Biology)
Article History
Received: 17 April 2024
Revised: 24 July 2024
Accepted: 30 July 2024
First Online: 21 August 2024
Disclosure and competing interests statement
: RBG is a consultant to City Fertility CHA Global and is a Scientific Advisory Board member to Cooper Surgical. MJB is currently an employee of Ferring Pharmaceuticals, which produce drugs used in reproductive medicine. LEW, HAH and DAS are co-founders, shareholders, directors and advisors of Jumpstart Fertility Inc, which was founded to develop NAD<sup>+</sup> precursors for the treatment of age-associated female infertility. The salaries of MJB and DG were paid in part by contract research from Jumpstart Fertility to UNSW. KS was an employee of Jumpstart Fertility. DJL is an employee and shareholder in Metro International Biotech, which is developing NAD<sup>+</sup> precursors as therapeutics for a range of conditions. LEW and DAS are advisors and shareholders in EdenRoc Sciences, the parent company of Metro Biotech NSW and Metro Biotech, and in Life Biosciences LLC and its daughter companies. DAS is also a founder, equity owner, advisor, director, consultant, investor and/or inventor on patents licensed Cohbar, Galilei Biosciences, Tally Health, EdenRoc Sciences, MetroBiotech, and Life Biosciences. He is an inventor on a patent application filed by Mayo Clinic and Harvard Medical School that has been licensed to Elysium Health. For a full list and details see . MMC is currently an employee of Gameto Inc., which is developing cell-based therapies for reproductive medicine.